Desh Bandhu Gupta, founder and Chairman of Lupin, India’s second-largest pharmaceutical company passed away on 26 June 2017 in Mumbai. He was 79.
Gupta had not been keeping well for some time and was not actively involved in the business for a few years. He is survived by his wife and five children.
Speaking on their father’s demise, Vinita Gupta and Nilesh Gupta, CEO and MD of Lupin said in a joint statement, “We are deeply saddened with the demise of our father. What DBG (Desh Bandhu Gupta) put in motion 50 years ago in helping to create, innovate and lead in the pharmaceutical space is an unparalleled legacy.”
The statement further added, “Those who knew and worked with DBG, remember him giving generously and fostering a dynamic environment where people could learn and grow. We will continue to build on his legacy and live by the values he instilled.”
About Desh Bandhu Gupta
• Born in Rajgarh, Rajasthan, Gupta earned a master’s degree in chemistry.
• He started his career as an associate professor at Birla Institute of Technology and Science (BITS), Pilani in Rajasthan.
• He had a vision to fight life-threatening diseases of highest national priority by delivering good quality medicines at an affordable price.
• With that objective he founded Lupin in the 1968 with a start-up capital of just Rs.5000.
• Under his leadership, Lupin grew from being a domestic Indian pharmaceutical company to a global pharmaceutical major worth a US$ 1.83 billion, spanning 100 countries.
• Lupin is one of the largest producers of tuberculosis medicines in the world.
• Gupta set up the Lupin Human Welfare & Research Foundation (LHWRF), one of the largest non-governmental organizations funded by a corporation in Southeast Asia, in October 1988.
• The main objective behind setting up of the foundation was to eradicate poverty by encouraging sustainable development at the grass root level in rural India.
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.